Institution
ACADIA Pharmaceuticals Inc.
Company•San Diego, California, United States•
About: ACADIA Pharmaceuticals Inc. is a company organization based out in San Diego, California, United States. It is known for research contribution in the topics: Pimavanserin & Receptor. The organization has 260 authors who have published 276 publications receiving 8418 citations.
Papers published on a yearly basis
Papers
More filters
3 citations
Patent•
25 Jul 2002TL;DR: In this paper, the authors provide compositions and methods for screening individuals for the presence of G-protein coupled receptor (GPCR) variants, which are useful for determining clinical outcome of drug therapy or for tailoring drug therapy for the individual based upon the presence or absence of one or more GPCR variants in the subject.
Abstract: The invention provides compositions and methods for screening individuals for the presence of G-protein coupled receptor (GPCR) variants. The compositions and methods are useful for determining clinical outcome of drug therapy or for tailoring drug therapy for the individual based upon the presence or absence of one or more GPCR variants in the subject.
3 citations
Patent•
17 Oct 2006TL;DR: Disclosed is a process for preparing a compound of formula A - N=C(D)(B) from a compound A-N =C(E) and a compound D-M using an iron catalyst, where the process has is represented by Equation (I).
Abstract: Disclosed is a process for preparing a compound of formula A - N=C(D)(B), from a compound of formula A-N=C(E)(B) and a compound of formula D-M using an iron catalyst, where the process has is represented by Equation (I).
3 citations
30 Oct 2009
TL;DR: The motivation-directed behavior of dopamine and striatum and the role of dopamine in motor control are studied in schizophrenia and Parkinson's disease.
Abstract: 1
Pyramidal Motor System
2
Limbic Motor Control: The Motive Circuit and Basal Ganglia
3
Flow of Information Through Motivational Circuitry
4
Dopamine and Motivated Behavior
5
Neuropsychiatric Indications
6
Summary
Keywords:
motivation;
goal-directed behavior;
motive circuit;
basal ganglia;
limbic system;
motor control;
prefrontal cortex;
striatum;
pallidum;
thalamus;
dopamine;
schizophrenia;
Parkinson's disease;
Huntington's disease
3 citations
Patent•
14 Dec 2017TL;DR: In this article, the authors present methods for the treatment of Alzheimer's disease psychosis, or symptom thereof, comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof.
Abstract: Methods for the treatment of Alzheimer's disease psychosis, or a symptom thereof, comprising administering pimavanserin. Also provided herein are methods for the treatment of delusions and/or hallucinations in a human with dementia comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof. Also provided herein are methods for reducing NPI- NH score in a human with Alzheimer's Disease comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof. Also provided herein are methods for reducing agitated behavior or aggressive behavior in a human with dementia comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof.
3 citations
Authors
Showing all 261 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Michael Bachmann | 63 | 360 | 14388 |
| Daniel P. van Kammen | 47 | 168 | 6957 |
| Kristina Luthman | 39 | 158 | 7344 |
| Fredrik Almqvist | 37 | 170 | 4219 |
| Mark R. Brann | 35 | 77 | 5579 |
| Roger Olsson | 30 | 138 | 2752 |
| Uli Hacksell | 29 | 99 | 2954 |
| Torbjörn Frejd | 29 | 165 | 2889 |
| Petrine Wellendorph | 27 | 83 | 2573 |
| Ethan S. Burstein | 27 | 70 | 2255 |
| David M. Weiner | 26 | 45 | 3230 |
| Kimberly E. Vanover | 25 | 70 | 1955 |
| Uli Hacksell | 25 | 129 | 2879 |
| Magnus Gustafsson | 25 | 94 | 1546 |
| Mark R. Brann | 24 | 39 | 2576 |